6-10770188-A-G
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_001242957.3(MAK):āc.1715T>Cā(p.Ile572Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00349 in 1,614,144 control chromosomes in the GnomAD database, including 26 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001242957.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAK | NM_001242957.3 | c.1715T>C | p.Ile572Thr | missense_variant | 14/15 | ENST00000354489.7 | NP_001229886.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAK | ENST00000354489.7 | c.1715T>C | p.Ile572Thr | missense_variant | 14/15 | 5 | NM_001242957.3 | ENSP00000346484.3 | ||
ENSG00000272162 | ENST00000480294.1 | n.100+20490A>G | intron_variant | 2 | ENSP00000417929.1 |
Frequencies
GnomAD3 genomes AF: 0.00471 AC: 717AN: 152192Hom.: 2 Cov.: 32
GnomAD3 exomes AF: 0.00375 AC: 943AN: 251294Hom.: 7 AF XY: 0.00373 AC XY: 507AN XY: 135812
GnomAD4 exome AF: 0.00337 AC: 4921AN: 1461834Hom.: 24 Cov.: 31 AF XY: 0.00346 AC XY: 2519AN XY: 727222
GnomAD4 genome AF: 0.00471 AC: 717AN: 152310Hom.: 2 Cov.: 32 AF XY: 0.00478 AC XY: 356AN XY: 74488
ClinVar
Submissions by phenotype
not provided Benign:3
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Apr 01, 2018 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | May 18, 2015 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Institute for Genomic Medicine (IGM) Clinical Laboratory, Nationwide Children's Hospital | May 08, 2017 | BS1,BP4; This alteration has an allele frequency that is greater than expected for the associated disease, and is predicted to be tolerated by multiple functional prediction tools. - |
Retinitis pigmentosa 62 Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | Jun 28, 2017 | - - |
Likely benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Nov 29, 2023 | - - |
Retinitis Pigmentosa, Recessive Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at